SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001401914-24-000002
Filing Date
2024-01-29
Accepted
2024-01-29 16:18:34
Documents
1
Period of Report
2024-01-26

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1706563099.html 3  
1 FORM 3 wk-form3_1706563099.xml 3 8971
  Complete submission text file 0001401914-24-000002.txt   10631
Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Issuer) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 16870 WEST BERNARDO DRIVE SUITE 120 SAN DIEGO CA 92127
Business Address
Haring-Layton MarDee (Reporting) CIK: 0001535596 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36395 | Film No.: 24573903